The Cell Banking Outsourcing Market, valued at USD 12.5 billion in 2023, is projected to reach USD 41.54 billion by 2031, with a CAGR of 16.2% during 2024-2031. This growth underscores rising demand for outsourcing services in cell banking, driven by complexities in cell-based therapies, stringent regulations, and the need for cost-effective solutions. Outsourcing offers access to expertise and facilities, allowing companies to focus on core activities and accelerate product development. As the biopharmaceutical industry expands, cell banking outsourcing will play a vital role in advancing therapeutics and biotechnology